Normativa para el tratamiento del tabaquismo

Archivos de Bronconeumologia

Volumn 35, Issue 10, 1999, Pages 499-506

  Jimenez Ruiz C A ^a   Solano Reina, S ^b   Gonzalez De Vega J M ^b   Ruiz Pardo, M J ^b   Florez Martin S ^b   Ramos Pinedo, A ^b   Barrueco Ferrero, M ^b   Carrion Valero F ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; ARTICLE; FOLLOW UP; HUMAN; METHODOLOGY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; PULMONOLOGY; RECURRENT DISEASE; SMOKING; SMOKING CESSATION; SOCIAL SUPPORT; SPAIN; THORAX SURGERY;

FOLLOW-UP STUDIES; HUMANS; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; PULMONARY DISEASE (SPECIALTY); RECURRENCE; SMOKING; SMOKING CESSATION; SOCIAL SUPPORT; SPAIN; THORACIC SURGERY;

EID: 0347386323     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30025-9     Document Type: Article

References (69)

1. Peto R, López AD, Boreham J, Thun M, Heath C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1.992; 339: 1.268-1.278.
2. 1. The Lung Health Study. JAMA 1994; 272: 1.497-1.505.
3. Indicadores de salud, información sanitaria y epidemiológica. Madrid: Ministerio de Sanidad y Consumo, 1990.
4. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996; 34-36.
5. a ed.). Philadelphia: Lippincott, 1994; 673-722.
6. Smoking and Health. A physician responsability. A statement of the Joint Committee on Smoking and Health. Eur Respir J 1.995; 8: 808-811.
7. Prochazka J; Diclemente CC. Stages and processes of self change of smoking: toward an integrative model of change. J Consult Clin Psychology 1983; 51: 390-395.
8. Prochazka J, Diclemente CC, Velicer W. Predicting change in smoking status for self changers. Addict Behav 1985; 10: 395-406.
9. Jiménez Ruiz CA, Gonzalez de Vega JM, Escudero C, García A, Roca J, Solano S et al. Tabaquismo. Madrid: Manuales SEPAR (vol. 1), 1995; 1-109.
10. Orleans C, Gerorge L, Houpt J. Health promotion in primary care: a survey of US family practitioners. Prevent Med 1985; 14: 636-647.
11. Ockene JK. Physician-delivered interventions for smoking cessation: strategies for increasing effectiveness. Prevent Med 1987; 16: 723-737.
12. Marlatt G, Gordon J. Relapse prevention: maintenance strategies in the treatment of adictive behaviours. Nueva York. Guilford Press, 1985.
13. Glynn T, Manley M. How to help your patients stop smoking? National cancer Institute. Manual for physicians (NIH publication No. 90-3064). Bethesda. Smoking, Tobacco and Cancer Program. Division of cancer prevention and control. Washington, National Cancer Institute, 1989.
14. Stapleton JA, Russell MAH, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U et al. Dose effects and predictors of outcome in a randomizet trial of transdermal nicotine patches in general practice. Addiction 1995; 90: 31-42.
15. Kottke T, Battiste R, DeFriese G, Brekkg ML. Attitudes of successful smoking cessation intervention in medical practice: a metaanalysis of 39 controlled trials. JAMA 1988; 259: 2.883-2.889.
16. Research Committee of the British Thoracic Society. Smoking cessation in patients: two futher studies by the British Thoracic Society. Thorax 1990; 45: 835-840.
17. Tønnesen P. Smoking cessation programs. En: Hansen HH, editor. Lung cancer. Boston: Kluwer Academic Publishers, 1994; 75-89.
18. Russell MAH, Wilson C, Taylor C, Baker CD. Effect of general practitioners advice against smoking. BMJ 1.979; 2: 231-235.
19. Stewart P, Rosser WW. The impact of routine advice on smoking cessation from family physicians. Can Med Assoc J 1982; 126: 1.051-1.054.
20. Jamrozik F, Fowler G, Vessey M. Controlled trial of three different antismoking interventions in general practice. BMJ 1984; 288: 1.499-1.503.
21. Slama K, Karsenty S, Hirsh A. Effectiveness of minimal intervention by general practitioners with their smoking patients: a randomised, controlled trial in France. Tobacco Control 1995; 4: 162-169.
22. Tønnesen P, Mikkelsen C, Markholst A, Ibsen A, Bendixen M, Pedersen L et al. Nurse-conducted smoking cessation with minimal intervention in a lung clinic: a randomized controlled study. Eur Respir J 1996; 9: 2.351-2.355.
23. Jiménez Ruiz CA, Barrueco Ferrero M, Carrión Valero F, Cordovilla R, Hernández I, Martínez Moragón E et al. Intervención mínima personalizada en el tratamiento del tabaquismo. Resultados de un estudio multicéntrico. Arch Bronconeumol 1998; 34: 433-436.
24. US Department of Health and Human Services. The health consequences of smoking: chronic obstructive lung disease. A Report of the Surgeon General. US Department of Health and Human Services. Office on Smoking and Health. Washington: DHHS. Publication No. 84-50205. Washington DC: US Government Printing office, 1984.
25. Cummings SR, Rubin SM, Oster G. The Cost-effectiveness of counseling smokers to quit. JAMA 1989; 251: 75-79.
26. Anda RF, Remington PL, Sienko DG, Davis RM. Are physicians advising smokers to quit? The patient's perspective. JAMA 1987; 257: 1.916-1.919.
27. ¿Se realiza intervención mínima en tabaquismo en nuestro país? Arch Bronconeumol 1995; 1 (Supl): 24.
28. Hajek P. What "behavioural supplement" is neccesary for nicotine replacement to work? Future Directions in Nicotine Replacement Therapy 1993; 28.
29. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström tolerance nicotine questionnaire. J Behav Med 1989; 12: 159-182.
30. US. Department of Health and Human Services. The health consequences of smoking: nicotine addiction. A report of the Surgeon General. DHS Publication No. (CDC) 88-8406. Washington DC: US Government Printing office, 1988.
31. Klesges RC, Meyers AW, Winders SE, French SN. Determining the reasons for weight gain following smoking cessation: Current findings, methodological issues and future directions for research. Ann Behav Med 1989; 11: 134-143.
32. Kuck LA. Weight Management: a special problem for smoking cessation among women. Sem Res Cr C Med 1995; 16: 104-110.
33. Perkins KA. Weight gain following smoking cessation. J Consult Clin Psychol 1993; 61: 768-777.
34. Fagerström KO. Reducing the weight gain after stopping smoking. Addict Behav 1987; 12: 91-93.
35. Schneider N. Nicotine therapy in smoking cessation. Pharmacokinetic considerations. Clin Pharmacokinet 1992; 23: 169-172.
36. Benowitz N. Pharmacological aspects of cigarettes smoking and nicotine addiction. N Engl J Med 1988; 319: 1.318-1.330.
37. Jiménez Ruiz CA, Solano S. Tratamiento del tabaquismo. Terapia sustitutiva con nicotina. Rev Clin Esp 1994; 194: 487-491.
38. Fagerström KO. Effects of nicotine chewing gum and follow-up appointments in physician based smoking cessation. Prevent Med 1984; 13: 517-527.
39. Tønnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H et al. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 1988; 318: 15-18.
40. Tønnesen P, Fryd V, Hansen M et al. Two and four mg nicotine chewing gum and group counseling in smoking cessation: an open, randomized, controlled trial with a 22 month follow up. Addict Behav 1988; 13: 17-27.
41. Abelin T, Buehler A, Müller P, Vesanen K, Imhof P. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989; 1: 7-10.
42. Tønnesen P, Nørregaard J, Simonsen K, Sawe U A double blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-315.
43. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six month results from two multicenter controlled clinical trials. JAMA 1991; 266: 3.133-3.138.
44. Fiore MC, Jorenby DE, Baker T, Kenfor SL. Tobacco dependence and the nicotine patch, clinical guidelines for effective use. JAMA 1992; 268: 2.687-2.694.
45. Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN et al. Effect of transdermal nicotine delivery as an adjunt to low intervention smoking cessation therapy: a randomized, placebo-controlled double-blind study. Arch Intern Med 1991; 151: 749-752.
46. Collaborative European Anti-Smoking Evaluation Study. European Respiratory Annual Congress. Estocolmo, septiembre de 1996.
47. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139-142.
48. Sutherland G, Stapleton J, Russell MAH, Jarvis M, Hajek P, Belcher M et al. Randomized controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992; 340: 324-329.
49. Tønnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993; 269: 1.268-1.271.
50. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation. A placebo-controlled clinical trial. Prevent Med 1995; 24: 41-47.
51. Hughes J, Cummings M, Hyland A. Ability of smokers to reduce their smoking and its association with future smoking cessation. Addiction 1999; 94: 109-114.
52. Sachs D, Benowitz N. Individualizing medical treatment for tobacco dependence. Eur Respir J 1996; 9: 629-631.
53. Paoletti P, Fornai E, Maggiorelli F, Puntoni R, Viegi G, Carrozzi L et al. Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. Eur Respir J 1996; 9: 643-651.
54. ¿Son realmente útiles?. Arch Bronconeumol 1996; 32: 435-436.
55. Tønnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, Gulsvik A et al, members of the Steering Committe of CEASE on behalj of the European Respiratory Society. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur Respir J. 1999; 13: 238-246.
56. Schneider N, Lunell E, Olmstead RE, Fagerström KO. Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems. Clin Pharmacokinet 1996; 31: 65-80.
57. Hjalmarson A, Franzon M, Westin A, Wiklund O. Effect of nicotine nasal spray on smoking cessation: a randomised, placebo-controlled, double-blind study. Arch Intern Med 1994; 154: 2.567-2.572.
58. Schneider NG, Olmstead R, Mody FV, Doan K, Frauzon M, Jarvik M et al. Efficiency of a nicotine nasal spray in smoking cessation: a placebo controlled, double-blind trial. Addiction 1995; 90: 1.671-1.682.
59. Blöndal T, Franzon M, Westin A. A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J 1997; 10: 1.585-1.590.
60. Blondal T, Gudmundsson L, Olafsdottir I, Gustausson G, Westin A. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 1999; 318: 285-288.
61. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994; 308: 21-26.
62. Kenford SL, Fiore MC, Jorenby DE, Smith S, Wetter D, Baker, T.B. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 1994; 271(8): 589-594.
63. Jorenby DE, Smith SS, Fiore M, Hurt R, Offord KP, Croghan IT et al. Varying nicotine patch dose and type of smoking cessation counseling. JAMA 1995; 274(17): 1.347-1.352.
64. Dale LC, Hurt R, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. JAMA 1995; 274(17): 1.353-1.358.
65. Glass RM. Blue mood, blackened lungs: depresion and smoking. JAMA 1990; 264: 1.583-1.584.
66. Hall SM, Muñoz R, Reus V. Smoking cessation, depresion and dysphoria. NIDA Res. Monogr. 1991; 105: 312-313.
67. Ascher JA, Cole JO, Feighner JP, Ferris RM, Fibiger HC, Golden RN et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995; 56: 395-401.
68. Hurt R, Sachs D, Glover E, Offord K, Johnston J, Dale L et al. A comparison of instained-relaise bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1.195-1.202.
69. Jorenby DE, Leischow SJ, Nides MA, Rennard ST, Johnston JA, Hughes AR et al. A controlled trial of sustained released bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-691.